1. Home
  2. MOH vs GKOS Comparison

MOH vs GKOS Comparison

Compare MOH & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molina Healthcare Inc

MOH

Molina Healthcare Inc

HOLD

Current Price

$197.37

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$160.94

Market Cap

10.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOH
GKOS
Founded
1980
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
10.6B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
MOH
GKOS
Price
$197.37
$160.94
Analyst Decision
Hold
Strong Buy
Analyst Count
13
12
Target Price
$167.00
$126.92
AVG Volume (30 Days)
437.6K
567.1K
Earning Date
04-22-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.46
N/A
Revenue
$45,426,000,000.00
$507,442,000.00
Revenue This Year
$2.40
$23.32
Revenue Next Year
$5.18
$27.43
P/E Ratio
$137.99
N/A
Revenue Growth
11.75
32.33
52 Week Low
$121.06
$73.16
52 Week High
$244.89
$191.62

Technical Indicators

Market Signals
Indicator
MOH
GKOS
Relative Strength Index (RSI) 45.24 36.95
Support Level $196.50 $145.78
Resistance Level $204.11 $161.53
Average True Range (ATR) 6.39 6.75
MACD 0.08 -2.59
Stochastic Oscillator 35.10 8.62

Price Performance

Historical Comparison
MOH
GKOS

About MOH Molina Healthcare Inc

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: